ALBERT BOURLA - 30 Apr 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role: Chairman & CEO, Director
Signature: /s/ Shanice A. Reid, by power of atty., for Albert Bourla
Issuer symbol: PFE
Transactions as of: 30 Apr 2025
Net transactions value: +$610
Form type: 4
Filing time: 02 May 2025, 13:35:56 UTC
Previous filing: 17 Apr 2025
Next filing: 19 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BOURLA ALBERT	Chairman & CEO, Director	66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK	/s/ Shanice A. Reid, by power of atty., for Albert Bourla	02 May 2025	0001595703

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Phantom Stock Units SSP	Award	$610	+25	+0%	$24.41	705,968	30 Apr 2025	Common Stock	25		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each unit represents one phantom share of common stock.
F2	These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.